Lipofit Extreme 2.0 Fat Burner Dietary Supplement
Product details
- Lipofit Extreme 2.0 Fat Burner Dietary Supplement
Company announcement
Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0 (Lot 25M12F, expiration date September 2027) nationwide.
The product contains undeclared fluoxetine in the daytime tablets and undeclared 2,4-dinitrophenol (DNP) in the nighttime tablets.
Fluoxetine is an active ingredient in an FDA-approved drug, and DNP is a toxic substance not approved for any use.
No adverse events related to this recall have been reported to date.
Risk:
Lipofit Extreme 2.0 Fat Burner, is a product promoted and sold for weight loss. When tainted with both fluoxetine and DNP, Lipofit Extreme 2.0 Fat Burner can cause a wide range of serious and potentially life-threatening adverse effects. Users may experience nausea, vomiting, sweating, dizziness, and headaches, as well as dangerous heart rhythm problems, rapid heart rate, and cardiac arrest, which can result in sudden death. Neurological effects including seizures may also occur, along with abnormal bleeding and suicidal thoughts. Long-term exposure carries additional risks, including damage to the eyes, skin, bone marrow, nervous system, and heart, as well as dangerously high body temperature and rapid breathing. When combined with certain other medications, the risk of fatal cardiac events is further elevated. To date, Ana Salazar Modela Tu Cuerpo Inc. has not received any known reports of adverse events related to this recall.
Impacted states: Nationwide
Products:
- Lipofit Extreme Fat Burner 2.0
Contact
For more information, call (954) 305-1004 or email yandrydy@gmail.com.